Similarly, compared with the NB patients in the MYCN-non-amp group, tumor suppressor gene expression was relatively lower in the MYCN-amp group (n=8 vs. n=6; Figure 7A; right panel), whereas oncogene expression was relatively higher in the MYCN-amp group (Figure 7B; right panel). The gene discussed is MYCN; the disease is neuroblastoma.